Why:
- Last year's growth was bought, and the rest of the group stood still. 82% of the FY26 revenue increase was the first full year of one 51%-owned acquisition, the pharma forwarder Odyssey Logistics. Strip it out and revenue grew about 4%, the owners' share of profit from the pre-existing business fell roughly 30%, and earnings per share declined, because 35% of group profit now belongs to the minority partners in the subsidiaries (T1).
- The business rents everything it sells. Skyways buys space on other people's aircraft shipment by shipment, holds no rate contracts with any airline, and its own filing says pricing usually decides tenders while foreign carriers control 94 to 95% of the market's volumes. The volume growth is real, but the spread it keeps is 11 paise per rupee, re-earned every year (T1).
- A live criminal case sits on the franchise. A Delhi Economic Offences Wing FIR names the company itself in an alleged bribery and inflated-invoicing scheme claiming at least ₹44 crore, and India Customs suspended its trusted-trader (AEO) status in May 2026 with revocation proposed. The earlier attempt at this IPO was pulled five weeks after the FIR reached the national press (T1, T3).
What the price buys
| Floor ₹131 (T1) | Cap ₹138 (T1) | |
|---|---|---|
| Bid window | 24 to 27 August 2026 | |
| Bid lot | 100 shares | |
| Fresh shares (fixed count) | 2,88,98,300 | 2,88,98,300 |
| Post-issue shares | 14,53,43,544 | 14,53,43,544 |
| Market capitalisation | ₹1,904 cr | ₹2,006 cr |
| P/E (FY26 profit to owners) | 46.4x | 48.9x |
| P/E (consolidated profit, incl. the minorities' 35%) | 30.0x | 31.6x |
| EV/EBITDA (net debt as reported) | 19.1x | 19.9x |
| EV/EBITDA (after the ₹217 cr earmarked debt repayment) | 17.4x | 18.2x |
| Promoter holding after | 56.8% | 56.8% |
The four peers the filing prints are domestic express and contract-logistics companies, not freight forwarders, and its own note concedes they are not strictly comparable, so the offer carries no like-for-like comparison. The price does not move the verdict; the six ratings judge the business, not the tag.
The story
A buyer of this IPO is being offered India's most active air freight forwarder: a 42-year-old Delhi consolidator that moved 84,000 tonnes of air cargo last year and says it books more air consignments out of India than anyone. The story under the headline is thinner: the dramatic FY26 numbers are mostly one bought company's first full year, the No. 1 rank counts waybills rather than tonnes (a consolidator of many small shipments tops it almost by construction), and the profit that reaches the listed shareholder has barely moved.
What this business is
Skyways sells space on other people's aircraft and ships. It buys belly and freighter capacity from 56 airlines, consolidates cargo from its 9,500 customers (including smaller forwarders who tender their loads to it), issues the airway bill, and clears customs under a broker licence held since 1984. Air freight is 77% of revenue, ocean 15%, and a domestic express parcel network, trucking, warehousing and a retail experiment make up the rest, most of them loss-making at small scale. About 23% of FY26 revenue is pharmaceuticals, largely through Odyssey, the cold-chain specialist it bought control of in January 2025 (T1).
Because freight is billed gross, revenue mostly tracks carrier rates. The company's real top line is the spread between what it pays carriers and what it charges: ₹306 crore in FY26, up 32% in the year, of which a rising 41% converts to operating profit (T1).
Easy or difficult business? Run-of-the-mill at the structural level: the licences are held by hundreds of agents, the company charters nothing and owns no capacity, and its own risk factors call the industry highly fragmented with pricing usually decisive. The difficulty it has actually built is commercial: forty years of carrier relationships, tonnage rebates hit in 13 of 15 recent carrier-years, and a customer book so wide that the top ten are only a fifth of revenue (T1).
Key numbers
| ₹ cr | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Revenue | 1,289 | 2,248 | 2,813 |
| Revenue growth % | -13.1 | 74.4 | 25.1 |
| Gross margin % | 11.8 | 10.3 | 10.9 |
| EBITDA | 48 | 86 | 126 |
| EBITDA margin % | 3.8 | 3.9 | 4.5 |
| PAT (to owners) | 31 | 39 | 41 |
| PAT growth % | n/a | 25.3 | 4.7 |
Read the middle year with care: FY25's 74% jump was mostly the Red Sea crisis lifting freight rates 31% to 82%, and FY26's 25% is mostly Odyssey consolidating for twelve months (its contribution rose ₹463 crore). Like-for-like, FY26 revenue grew 3 to 5%. Consolidated PAT (₹64 crore, up 32%) is the number the filing leads with; the owners' share above is the one a buyer of these shares gets, and 88% of last year's profit increase went to the minority partners instead. One more caution: the year's strong ₹114 crore operating cash flow leans on a fourth-quarter payables jump in the one quarter for which no stock statement was filed with the lenders (T1).
| Segment, ₹ cr | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Air cargo | 1,021 | 1,641 | 2,166 |
| Air cargo growth % | n/a | 60.7 | 32.0 |
| Ocean cargo | 165 | 395 | 423 |
| Ocean cargo growth % | n/a | 139.2 | 7.1 |
| Express parcel | 59 | 141 | 163 |
| Express parcel growth % | n/a | 140.1 | 15.3 |
Profit by segment is not disclosed. Ten of eighteen subsidiaries lost money in FY26, led by the express arm (₹4.5 crore loss, widening); the air-ocean core carries them (T1).
Scorecard
| Block | Rating | Why |
|---|---|---|
| Right to win | MARGINAL | The franchise is real: 6%-odd of India's air export tonnage, four straight years as the most active consignment booker, 56 carrier relationships with no top-10 supplier lost in three years, and volumes growing well ahead of a 3 to 6% market even before the acquisition. What stops a pass: it owns no capacity and holds no rate contracts, its suppliers control 94 to 95% of the market and reprice annually, the loyalty evidence it publishes runs the wrong way (its named legacy clients grew 18.5% over two years against 118% for the company), and part of its share is other forwarders' cargo passing through its consolidation. |
| Industry and TAM | MARGINAL | Headroom is real: even 6% of exports leaves nearly all the pool unserved, and imports are untouched. But the pool itself grows low single digits in tonnes, every rupee of runway must be taken from competitors the filing never names, and the year's celebrated pharma surge was the bought company's book consolidating inside a flat pharma export market. |
| Financial momentum | MARGINAL | The genuine good news is operating leverage: the spread grew 32% and its conversion to profit has risen nine points in two years. Against it: like-for-like growth of 3 to 5%, returns on all capital of about 12% (not the reported 18%), three years of negative free cash flow before acquisitions, and a big cash-flow year resting on an unverified quarter-end payables balance. |
| Risks, governance, RPTs | MARGINAL | Related-party dealings are small and the disclosure is unusually candid. But a live EOW FIR names the company in an alleged bribery and inflated-invoicing scheme, customs suspended its trusted-trader status in May 2026 with revocation proposed, six tax appeals were lost at first level (₹36.5 crore claimed), and the control environment trails the group's pace: three insider frauds, audit trails off at four subsidiaries, and bank stock statements that disagree with the books. |
| Promoter and cap table | MARGINAL | Four decades of real operating history and the promoters keep 57% after selling only a tenth of their stock. But the owners' profit has barely grown, a third of earnings belongs to minority partners, two directors received a fifth of their stock free from a promoter weeks before a bonus issue and are now exiting nearly half of what they hold, and the company paid the promoters ₹18 crore for land with no valuation disclosed while every third-party deal got one. |
| Offer structure | MARGINAL | Two rupees in three enter the company, a monitoring agency is appointed, and the debt being repaid genuinely funded acquisitions and buildings. But nearly half of it is revolving working-capital paper the filing itself expects to be redrawn, and the ₹130 crore working-capital object assumes a 41% standalone revenue year straight after a 5% one while spending most of itself replacing free supplier credit. |
Watch out for
- The FIR and the customs suspension. The complainant, a UK paper trader, claims losses of at least ₹44 crore against roughly ₹59 crore of total business the group ever did with it. Nothing is adjudicated and the company denies everything, but the trusted-trader suspension is already in force, the revocation question is open, and an escalation would sit directly on the customs-and-forwarding franchise (T1, T3).
- Minority partners take a growing third of the profit. The group grows by buying 51% stakes; minorities took 9% of profit two years ago, 35% now. Unless future deals are structured differently, consolidated growth will keep overstating what the listed shareholder receives (T1).
- The FY27 pharma comparison may flatter and then payback. Independent reporting points to Indian pharma shippers front-loading US-bound air cargo ahead of tariff deadlines in 2026, after a FY26 in which pharma exports to the US actually fell. A strong first half would not prove the franchise; watch the second (T2, T3).
- Receivables are ageing under thin cover. Bills more than six months old doubled in FY26 to 6.4% of receivables while the provision stayed at 0.6%. Days look fine; the tail does not (T1).
The offer
- Raising ₹379 to 399 crore of fresh money at the band, plus an offer for sale of 1.33 crore shares, all by insiders: the two promoters selling about a tenth of their holdings, and two executive directors selling 40 to 46% of theirs (T1).
- For ₹217 crore of debt repayment and ₹130 crore of working capital, with the balance for general purposes; nothing for the infrastructure build the strategy chapter describes (T1).
- Implied valuation at the band: ₹1,904 to 2,006 crore, from the table above.
- Promoters hold 79.1% before the offer and about 56.8% after (T1).
Assessment of the Red Herring Prospectus dated 11 August 2026, obtained from SEBI's public filings. This is the offer's second attempt; a March 2026 issue was withdrawn before opening. Outside checks of the market data, the acquisition's standalone record, the FIR's press and exchange-disclosure trail and the ranking's basis were made and are marked where used (T2/T3). Numbers carry source tiers: (T1) the filing's audited sections and exchange records, (T2) established outside data with a named source, (T3) mainstream press or the issuer-commissioned industry chapter. Not a recommendation. The valuation section states what the announced band implies and is not a view on whether that price is right.